The upgrade is based on Moody’s expectation of robust earnings growth for Eli Lilly in the coming years. This growth is anticipated to be driven by the company’s incretin portfolio, which includes ...
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback